Adaptimmune Therapeutics plc

  • Home
  • Our Company
    • Overview arrow_forward
    • Partners arrow_forward
    • Board of Directors arrow_forward
    • Leadership Team arrow_forward
    • Scientific Advisory Board arrow_forward
    • Perspectives arrow_forward
    • COVID-19 arrow_forward
  • Pipeline
    • Overview arrow_forward
    • ADP-A2M4 arrow_forward
    • ADP-A2M4CD8 arrow_forward
    • ADP-A2AFP arrow_forward
    • ADP-A2M10 arrow_forward
  • Technology
    • Overview arrow_forward
    • Manufacturing arrow_forward
    • Publications arrow_forward
  • Patients & Families
    • Overview arrow_forward
    • Taking Part in Our Clincial Trials arrow_forward
    • Cancer Info arrow_forward
    • Cancer Immunotherapy Month arrow_forward
    • Videos arrow_forward
    • Engagement with Patient Organizations arrow_forward
  • Clinical Trials
  • Investors & Media
    • Overview arrow_forward
    • News & Events arrow_forward
    • Annual Shareholder Meeting arrow_forward
    • Company Info arrow_forward
    • Financial Info arrow_forward
    • Stock Data arrow_forward
    • SEC Filings arrow_forward
    • Governance arrow_forward
    • Media arrow_forward
  • Contact
  • Careers
    • Overview arrow_forward
    • U.S. Careers arrow_forward
    • UK Careers arrow_forward

Press Releases

Investors & Media

Investors & Media

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Annual Shareholder Meeting
  • Company Info
    • Overview
    • Leadership Team
    • Board of Directors
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Media
  • News & Media

  • Press Releases
  • Presentations
  • Events
Nov 12, 2015 10:17am EST

Adaptimmune to Participate in the Jefferies Autumn 2015 Global Healthcare Conference

Nov 05, 2015 8:15am EST

Adaptimmune Announces Data From Clinical Study of NY-ESO Affinity Enhanced T-Cell Therapy in Synovial Sarcoma at the 2015 Annual Meeting of the Society of Immunotherapy for Cancer (SITC)

Oct 30, 2015 9:00am EDT

Adaptimmune Announces Upcoming Data Presentation at the 2015 Annual Meeting of the Society of Immunotherapy for Cancer (SITC)

Oct 16, 2015 10:00am EDT

Adaptimmune to Participate in the 2015 BIO Investor Forum

Oct 13, 2015 6:00am EDT

Adaptimmune Reports Full Fiscal Year 2015 Financial Results

Oct 09, 2015 8:30am EDT

Adaptimmune Growth Leads to Long-Term Expansion Plans in Philadelphia

Oct 07, 2015 9:14am EDT

Adaptimmune to Report Full Fiscal Year 2015 Financial Results on October 13, 2015

Oct 06, 2015 7:00am EDT

Adaptimmune Announces New Research and Development Facility in Oxfordshire

RSS
  • Prev
  • 1...
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • Email Alerts
  • Tear Sheet
  • Contacts
  • RSS News Feed
Adaptimmune Therapeutics plc
Privacy Policy Disclaimer Search Sitemap Terms of Use Supply Terms
Linedin Twitter Youtube
© 2021 Adaptimmune Therapeutics plc. All Rights Reserved.